Format

Send to

Choose Destination
Prostate. 2015 Sep;75(12):1300-11. doi: 10.1002/pros.23013. Epub 2015 Jun 5.

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.

Author information

1
Department of Surgery (Urology), Sunnybrook Health Sciences Center, Toronto, Ontario.
2
Department of Pathology, Sunnybrook Health Sciences Center, Toronto, Ontario.
3
Department of Analytical Pharmacology, Vancouver Prostate Group, Vancouver, British Columbia.
4
Department of Surgery (Urology), University Health Network, Princess Margaret Hospital, Toronto, Ontario.

Abstract

BACKGROUND:

Capsaicin, the active compound in chili peppers, has demonstrated anti- carcinogenic properties in vitro in a number of malignancies, including the prostate. In the present study, we investigate the chemopreventive potential of capsaicin on prostate cancer using the transgenic adenocarcinoma of the mouse prostate (TRAMP) model. The TRAMP is a murine model that resembles the progression of human disease.

METHODS:

Thirty-five 6-week-old TRAMP x C57BL/6 mice were randomized between treatment with capsaicin (5 mg/kg body weight) or control (saline) three times a week by oral gavage until 30 weeks of age. Body weight of animals was recorded thrice weekly. At termination, all tumors were extracted, recorded, and analyzed for histopathological analysis. To understand the effect of capsaicin on migration and invasion, in vitro experiments were carried out using PC3 cells.

RESULTS:

Mice in the control group expressed an overall trend of higher-grade disease with 37.5% poorly differentiated (PD), 18.75% moderately differentiated (MD), and 44% of well-differentiated (WD) adenocarcinoma, compared to the capsaicin-treated group with only 27.7% PD, 61.0% of WD, and 11.1% of intraepithelial neoplasia (PIN). The treatment group demonstrated a higher incidence of noncancerous PIN lesions compared to the control group. The capsaicin group also demonstrated a significant reduction (P < 0.05) in the metastatic burden compared to the controls, which correlated to a reduction in p27(Kip) (1) expression and neuroendocrine differentiation in prostate tumors. Furthermore, there were no differences in body weight between groups overtime, and no pathological toxicities in the liver and gastrointestinal tract with capsaicin consumption. In vitro studies revealed a dose-dependent reduction in the invasion and migration capacity of PC3 cells.

CONCLUSION:

The following study provides evidence supporting the safety and chemopreventive effects of capsaicin in the TRAMP model.

KEYWORDS:

capsaicin; invasion; metastasis; migration; prostate cancer; transgenic mice

PMID:
26047020
DOI:
10.1002/pros.23013
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center